We can generally trust that the medicines we buy at pharmacies contain what they are supposed to and that they were manufactured according to good quality standards. In his latest column, Dr Andy Gray zooms in on the regulatory scaffolding that enables this trust.
At his Durban office, Professor Willem Hanekom tells Biénne Huisman about taking a ventilated young patient to the Sea Point promenade, living with HIV, the need for an African research agenda, and the recurring joy that has defined his career.
Young people with kidney disease in South Africa often fall into the gap between the paediatric and adult healthcare systems. One innovative clinic in Cape Town is offering a solution tailor-made for this group. Elna Schütz reports.
Biénne Huisman meets South Africa’s recently appointed Deputy Director-General for HIV, AIDS, TB and sexually transmitted infections, discussing the latest HIV prevention medicines, her career turning points, and bedtime reading.
In part 3 of a Spotlight special series on the role of new weight loss medicines like Ozempic in South Africa, we ask what these breakthrough jabs might mean for people living with HIV in the country. There is some tantalising early research on potential benefits, but also many uncertainties. Catherine Tomlinson reports.
The Department of Health allows some public sector doctors and nurses to moonlight in the private sector, but the relevant policy and its implementation caused much controversy over the years. Set against the wider management dysfunction in several provincial health departments, the issue is now coming to a head. Joan van Dyk reports.
The media has reported several incidents where people were turned away at public healthcare facilities because they did not possess South African identity documents. As related cases slowly grind through the courts, Teri Brown and Thembi Mahlathi of SECTION27 connect the dots between what the law says and what people are experiencing.
Many regions in the Northern Hemisphere experienced a slightly earlier start to their flu season, driven in some part by a novel variant of influenza A(H3N2). As our flu season also kicks off slightly earlier than usual, Elri Voigt reports on detection of this variant in South Africa and what we might expect from this year’s flu season.
The sale of illegal medicines is a significant threat to public safety. In his latest Inside The Box column, Dr Andy Gray asks whether the South African Health Products Regulatory Authority has the necessary tools at hand to provide protection in this area.
Soft toys, giggly kisses, and bright wards buzzing with excited children meet a driven team of staff and researchers producing world class work at Brooklyn Chest Hospital’s paediatric TB research hub. Biénne Huisman visits the wards and the Desmond Tutu TB Centre’s clinical site as it celebrates ten years and gets early insight of a cutting-edge new treatment trial.
New TB tests have massive potential for South Africa’s struggle to get to grips with the age-old disease. Making the most of these new tests will require both ambition and smart implementation, argue Gaurang Tanna and Dr Yogan Pillay.
Universal health coverage cannot succeed with fragmented systems, weak data, and largely symbolic participation. A recent court-ordered pause to NHI implementation offers a chance to build the foundations properly, argue Dr Haseena Majid and Professor Mogie Subban.
